Reviva Pharmaceuticals Holdings, Inc. · NASDAQ:RVPH

Reviva Pharmaceuticals Holdings, Inc. financial statements

Reviva Pharmaceuticals Holdings, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019
Research and development11.7M22.9M31.4M22.9M4.85M295.1K195.7K
Operating income-20.2M-30.8M-39.5M-28.2M-10.1M-2.43M-724.7K-376.9K
Depreciation and amortization0591645
EBITDA-10.1M-2.43M-376.2K
Interest expense13.4K18.5K33.7K1.45M469.4K
Income before tax-19.8M-29.9M-39.2M-28.2M-8.52M-3.78M-846.0K
Income tax18.9K19.5K16.9K20.8K6.00K8000800
Net income-19.9M-29.9M-39.3M-28.3M-8.52M-3.78M617.9K-846.8K
Earnings per share, basic-5.48-17.73-1.65-1.45-0.58-1.24-0.21-0.31
Earnings per share, diluted-1.24-0.21-0.31

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019
Cash and equivalents14.4M13.5M23.4M18.5M29.7M8.76M69.3K193
Current assets15.1M14.7M23.7M138.9K
Property, plant and equipment0591
Total assets15.9M15.5M23.7M18.9M31.4M8.76M61.0M2.60K
Accounts payable3.01M6.28M3.85M3.52M509.6K1.01M299.7K224.5K
Current liabilities7.28M14.6M17.2M9.96M2.34M1.33M299.7K
Total liabilities7.28M14.7M18.0M10.5M2.72M3.30M3.26M6.81M
Shareholders' equity8.65M812.6K5.72M8.39M28.7M5.47M5.00M-6.81M
Shares outstanding5.87M2.36M27.9M20.4M14.4M9.23M2.70M15.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019
Cash from operations-24.6M-33.5M-28.3M-19.0M-10.7M-4.07M-426.6K-218.4K
Cash from investing5.70M
Cash from financing25.6M23.7M33.2M7.79M31.6M12.8M-5.52M100.0K
Change in cash962.5K-9.89M4.85M-11.2M20.9M8.76M-243.8K-118.4K